Aspect Biosystems and JDRF to Develop 3D Bioprinted Treatment for Diabetes
Canadian 3D bioprinting firm Aspect Biosystems has unveiled a new partnership with the international diabetes research and advocacy organization JDRF.
LATEST NEWS
- 09 / 17 : UTS Researchers Advance Study of Preeclampsia With Bioprinted Placentas
- 09 / 13 : Anatomy Warehouse and Erler-Zimmer Partner to Deliver 3D Printed Models to U.S. Schools
- 09 / 11 : Stanford’s breakthrough milli-spinner clears stroke-causing clots in minutes
- 09 / 10 : Innovative 3D printed talus surgery helps Hyderabad man walk again
- 09 / 10 : Penn State Researchers Explore 3D Bioprinting to Restore Blood Flow in Reconstructive Surgery
2025-09-18
